Connect with us

Business

Global WholeHealth Partners Corp (OTC: GWHP) Has Filed Applications to Sell Through WalMart, Amazon, Ebay and Soon Shopify

Published

on

Global WholeHealth Partners Corp (OTC: GWHP) through this agreement is funded for growth, sales, and expansion. Per the terms of the EMC2 Purchase Agreement, we may direct EMC2 to purchase up to $100,000,000 worth of shares of our common stock under our agreement over a 36-month period, generally in amounts up to 100,000 shares of our common stock, which may be increased to up to 2,000,000 shares of our common stock depending on the market price of our common stock at the time of sale and subject to a maximum commitment by EMC2 of $500,000 per regular purchase per day. The total amount of shares to be sold through the EMC2 agreement is up to 8,578,177 shares of common stock.

Global WholeHealth Partners Corp. (OTC:GWHP) provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases with an FDA Certificate of Exportability (2260-11-2019). The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.

GWHP develops, manufactures, and markets in vitro diagnostic (IVD) tests for OTC, or consumer-use as well as professional rapid diagnostic point-of-care (POC) test kits for hospitals, physicians’ offices, and medical clinics in the US and abroad. Currently, the Company has 70 products FDA approved and many are approved for OTC use, and 29 POC products approved by the FDA CLIA WAIVED.

Call or email about special prices for this announcement on all the tests.

Disclaimer:

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.

Media Contact:

Name: Charles Strongo,

CEO, Global WholeHealth Partners Corp.

Email: Sales@gwhpcorp.com Phone for Sales: 877-568-4947

www.gwhpcorp.com

Forward-Looking Statements

This press release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device industry from much larger, multinational companies, (v) product liability claims, (vi) product malfunctions, (vii) our limited manufacturing capabilities and reliance on subcontractors for assistance, (viii) insufficient or inadequate reimbursement by governmental and other third party payers for our products, (ix) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (x) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (xi) our reliance on single suppliers for certain product components, (xii) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xiii) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

Continue Reading
Advertisement

Business

Partnerships with Key Players Enables GWHP Corp To Source PPE Supplies and COVID-19 Diagnostic Testing Kits

Published

on

By

Looking for premium PPE supplies and COVID-19 tests during the pandemic? Global WholeHealth Partners is proud to announce that because of our longstanding relationship with key players in the industry, we are able to continually source high quality PPE supplies and COVID-19 diagnostic testing kits in wholesale quantities. As the Delta Variant makes its rounds and cases begin to climb, the continued use of PPE and following social distancing guidelines can help slow the spread of the coronavirus.

As we approach fall of 2021, COVID-19 and the contagious Delta Variant is still affecting the world at large. This is even with social distancing measures and mask mandates back in place in many areas. We all can do our part to help slow the spread of COVID-19 by social distancing where we can, staying quarantined when we are sick, and using PPE supplies when leaving the house. Masks wearing is required in most public indoor places such as shopping malls, grocery stores and restaurants and often times negative COVID-19 tests are required for travel.

GWHP Corp stands committed to sourcing these in demand products and we are hopeful that as more and more people continue to get vaccinated, that we will get ahead of the virus. For more information, simply visit our medical supply page to view our current inventory and get in touch with our specialists to place your wholesale PPE supplies order or wholesale COVID-19 diagnostic testing kits order. We can be reached at 877-568-4947.

About Global WholeHealth Partners OTC (GWHP)
GWHP provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines that detect between 1 – 1 ½ hours and Rapid Diagnostic Testing (RDT) Serum Plasma that detect between 15 -20 minutes, which predict diseases ahead of its industry competitors. Our focus is encompassing, improving, and preserving the quality of life by providing fast, adequate and accurate test results to prompt early treatment and cut cost of accumulated diseases all over the world. By so doing, GWHP has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. MISSION GWHP is committed to building long term shareholder value through the vertical integration of proven, well established business that effectively and efficiently control disease outbreak and significantly reducing health care costs. VISION Our vision is to lead the industry in infectious disease diagnostics and provide molecular solutions that lessen the time to diagnose medical results, empower healthcare professionals to make better diagnostic decisions, and lower healthcare costs.

Continue Reading

Business

Global WholeHealth Partners Provides Wholesale PPE Supplies and COVID-19 Diagnostic Testing Kits

Published

on

By

Heading into the fall season, COVID-19 cases are on the rise, in part due to the contagious Delta Variant that is making its rounds. Global WholeHealth Partners continues to do its part by supplying in demand PPE supplies and COVID-19 diagnostic testing kits in wholesale quantities to interested parties. With the continued distribution of the major vaccines, we are hopeful that COVID-19 cases will begin to decline. However, until then, the use of PPE supplies and COVID-19 diagnostic testing remains high and we are committed to offering these in demand products at competitive price points.

Even with the vaccines currently in distribution, it is important to remember that we can help slow the spread of COVID-19 by wearing masks in public spaces, social distancing when we can, and quarantining when we are sick. Masks wearing is required in most public indoor places such as shopping malls, grocery stores and restaurants and often times negative COVID-19 tests are required for travel.

Contact Global WholeHealth Partners today to place your order for wholesale PPE supplies or wholesale COVID-19 testing kits, or both, depending on your needs. We continue to source and supply these in demand products for our customers across the country. Call 877-568-4947 to start your order now.

About Global WholeHealth Partners OTC (GWHP)
GWHP provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines that detect between 1 – 1 ½ hours and Rapid Diagnostic Testing (RDT) Serum Plasma that detect between 15 -20 minutes, which predict diseases ahead of its industry competitors. Our focus is encompassing, improving, and preserving the quality of life by providing fast, adequate and accurate test results to prompt early treatment and cut cost of accumulated diseases all over the world. By so doing, GWHP has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. MISSION GWHP is committed to building long term shareholder value through the vertical integration of proven, well established business that effectively and efficiently control disease outbreak and significantly reducing health care costs. VISION Our vision is to lead the industry in infectious disease diagnostics and provide molecular solutions that lessen the time to diagnose medical results, empower healthcare professionals to make better diagnostic decisions, and lower healthcare costs.

Continue Reading

Business

GWHP Corp Continues to Supply PPE Supplies and COVID-19 Tests As COVID-19 Cases Surge

Published

on

By

COVID-19 cases are on the climb, especially due to the contagious Delta Variant. Global WholeHealth Partners stands committed to sourcing and supplying in demand COVID-19 diagnostic testing kits and personal protective equipment to help keep you safe. We offer these products in large wholesale quantities and interested parties can visit our medical supply page to view current inventory levels. At this time, we can only do our best to protect ourselves and others by following recommended social distancing guidelines and PPE recommendations.

We are incredibly thankful and hopeful that the Pfizer, Moderna and other major vaccines are making their way to millions of people across the globe. However, continued use of PPE supplies will help slow the spread of the virus so we can end this pandemic. We all can do our part to help slow the spread of COVID-19 by social distancing where we can, staying quarantined when we are sick, and using PPE supplies when leaving the house. Masks wearing is required in most public indoor places such as shopping malls, grocery stores and restaurants and often times negative COVID-19 tests are required for travel.

Get in touch with Global WholeHealth Partners now to place your order for wholesale PPE supplies or wholesale COVID-19 testing kits, or both, depending on your needs. We continue to source and supply these in demand products for our customers across the country. Call 877-568-4947 to start your order now.

About Global WholeHealth Partners OTC (GWHP)
GWHP provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines that detect between 1 – 1 ½ hours and Rapid Diagnostic Testing (RDT) Serum Plasma that detect between 15 -20 minutes, which predict diseases ahead of its industry competitors. Our focus is encompassing, improving, and preserving the quality of life by providing fast, adequate and accurate test results to prompt early treatment and cut cost of accumulated diseases all over the world. By so doing, GWHP has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. MISSION GWHP is committed to building long term shareholder value through the vertical integration of proven, well established business that effectively and efficiently control disease outbreak and significantly reducing health care costs. VISION Our vision is to lead the industry in infectious disease diagnostics and provide molecular solutions that lessen the time to diagnose medical results, empower healthcare professionals to make better diagnostic decisions, and lower healthcare costs.

Continue Reading

Trending